Skip to content

How a Checklist and Mobile App Help Detect Genetic Cancer Risk in Children with Cancer

The feasibility and acceptability of genetic screening tools for cancer predisposition in pediatric oncology setting: a cross-sectional study - PEDONCGEN

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/109718
Enrollment
97
Registered
2026-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil

Sponsors

Dr Archana M V
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children ages from day one to eighteen years of age who are being treated or monitored for cancer at our department throughout the research period, whether they are new or old patients, as well as their parents or legal guardians.

Exclusion criteria

Exclusion criteria: Patients whose family history cannot be determined, for example, because no parent or guardian is accessible or families that refuse to participate are excluded

Design outcomes

Primary

MeasureTime frame
Percentage of patients for whom each screening tool could be completely used and median time to complete each instrument and staff ease of use assessment (survey)Timepoint: One year

Secondary

MeasureTime frame
The percentage of patients classified as high-risk by each technique The percentage of parents who say they would be prepared to carry out the suggested genetic testing if necessaryTimepoint: One year

Countries

India

Contacts

Public ContactDr Archana M V

Manipal Academy of Higher Education

archana.mv@manipal.edu9481935068

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026